UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000026801 |
|---|---|
| Receipt number | R000030752 |
| Scientific Title | A study about pathogenic diagnosis of Mycoplasma pneumoniae pneumonia |
| Date of disclosure of the study information | 2017/03/31 |
| Last modified on | 2017/03/31 14:35:34 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A study about pathogenic diagnosis of Mycoplasma pneumoniae pneumonia
Acronym
A study about pathogenic diagnosis of Mycoplasma pneumoniae pneumonia
Scientific Title
A study about pathogenic diagnosis of Mycoplasma pneumoniae pneumonia
Scientific Title:Acronym
A study about pathogenic diagnosis of Mycoplasma pneumoniae pneumonia
Region
| Japan |
Condition
Condition
Mycoplasma pneumoniae pneumonia
Classification by specialty
| Infectious disease | Pediatrics |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Recently, a rapid antigen detection assay for L7/L12 ribosomal protein (Ribotest Mycoplasma; Asahi Kasei) for diagnosis of Mycoplasma pneumoniae infection became available in Japan. However, the clinical usefulness of Ribotest is not established. To clarify the usefulness of Ribotest, we diagnosed with Mycoplasma pneumoniae pneumonia using Ribotest, both in non-epidemic period and in epidemic period.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Sensitivities, specificities and positive predictive values of Ribotest for M. pneumoniae pneumonia
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 0 | years-old | <= |
Age-upper limit
| 18 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Eligible patients were otherwise healthy children 0 - 18 years of age who were admitted with community-acquired pneumonia
Key exclusion criteria
We excluded the subjects from whom throat swabs or paired serum samples were not obtained.
Target sample size
1000
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Naoko Nishimura |
Organization
Konan Kosei Hospital
Division name
Departments of Pediatrics
Zip code
Address
137 Ohmatsubara, Takaya-cho, Konan-shi, Aichi 483-8704, Japan
TEL
0587-51-3333
naon@konan.jaaikosei.or.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kensei Gotoh |
Organization
Konan Kosei Hospital
Division name
Departments of Pediatrics
Zip code
Address
137 Ohmatsubara, Takaya-cho, Konan-shi, Aichi 483-8704, Japan
TEL
0587-51-3333
Homepage URL
idecc2b7@gmail.com
Sponsor or person
Institute
Konan Kosei Hospital
Institute
Department
Personal name
Funding Source
Organization
Konan Kosei Hospital
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 03 | Month | 31 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
We presented the results at the 47th annual meeting of the Japanese Society for Pediatric Infectious Diseases on November 1, 2015.
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2013 | Year | 11 | Month | 13 | Day |
Date of IRB
Anticipated trial start date
| 2014 | Year | 01 | Month | 01 | Day |
Last follow-up date
| 2016 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Prospective study
Management information
Registered date
| 2017 | Year | 03 | Month | 31 | Day |
Last modified on
| 2017 | Year | 03 | Month | 31 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030752
